Daiichi Sankyo Co Ltd 2020 IR
The report highlights Daiichi Sankyo Group's progress in its five-year business plan, focusing on the launch of its oncology product ENHERTU in the U.S. and Japan. The company established a new R&D strategy called '3 and Alpha' to maximize the value of its three lead antibody-drug conjugates (ADCs) and drive sustainable growth. In response to the COVID-19 pandemic, the group initiated the development of an mRNA vaccine (DS-5670) and a Nafamostat inhalation formulation. On the environmental front, the company achieved a 15.8% reduction in global CO2 emissions compared to fiscal 2015, exceeding its fiscal 2020 target. Additionally, the group promoted diversity and inclusion, increasing the percentage of women in managerial positions globally to 25.3%.
Company: Daiichi Sankyo Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2020
Type: IR
Pages: 106
Back to company
Daiichi Sankyo Co Ltd
Value Report
The report highlights Daiichi Sankyo Group's progress in its five-year business plan, focusing on the launch of its oncology product ENHERTU in the U.S. and Japan. The company established a new R&D strategy called '3 and Alpha' to maximize the value of its three lead antibody-drug conjugates (ADCs) and drive sustainable growth. In response to the COVID-19 pandemic, the group initiated the development of an mRNA vaccine (DS-5670) and a Nafamostat inhalation formulation. On the environmental front, the company achieved a 15.8% reduction in global CO2 emissions compared to fiscal 2015, exceeding its fiscal 2020 target. Additionally, the group promoted diversity and inclusion, increasing the percentage of women in managerial positions globally to 25.3%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Apr 1, 2019 - Mar 31, 2020
Fiscal Year
2019
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Women on Board
Women in Management
Employees